448 related articles for article (PubMed ID: 22100522)
1. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D.
Jones G; Prosser DE; Kaufmann M
Arch Biochem Biophys; 2012 Jul; 523(1):9-18. PubMed ID: 22100522
[TBL] [Abstract][Full Text] [Related]
2. CYP24A1 and kidney disease.
Petkovich M; Jones G
Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):337-44. PubMed ID: 21610497
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of vitamin D3 by cytochromes P450.
Sakaki T; Kagawa N; Yamamoto K; Inouye K
Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
[TBL] [Abstract][Full Text] [Related]
4. Mutations in CYP24A1 and idiopathic infantile hypercalcemia.
Schlingmann KP; Kaufmann M; Weber S; Irwin A; Goos C; John U; Misselwitz J; Klaus G; Kuwertz-Bröking E; Fehrenbach H; Wingen AM; Güran T; Hoenderop JG; Bindels RJ; Prosser DE; Jones G; Konrad M
N Engl J Med; 2011 Aug; 365(5):410-21. PubMed ID: 21675912
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
6. Bioengineering anabolic vitamin D-25-hydroxylase activity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V391L mutation.
Kaufmann M; Prosser DE; Jones G
J Biol Chem; 2011 Aug; 286(33):28729-28737. PubMed ID: 21697097
[TBL] [Abstract][Full Text] [Related]
7. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism.
Annalora AJ; Goodin DB; Hong WX; Zhang Q; Johnson EF; Stout CD
J Mol Biol; 2010 Feb; 396(2):441-51. PubMed ID: 19961857
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2.
Masuda S; Strugnell SA; Knutson JC; St-Arnaud R; Jones G
Biochim Biophys Acta; 2006 Feb; 1761(2):221-34. PubMed ID: 16516540
[TBL] [Abstract][Full Text] [Related]
10. Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity.
Tieu EW; Tang EK; Chen J; Li W; Nguyen MN; Janjetovic Z; Slominski A; Tuckey RC
Biochem Pharmacol; 2012 Dec; 84(12):1696-704. PubMed ID: 23041230
[TBL] [Abstract][Full Text] [Related]
11. Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.
Annalora AJ; Bobrovnikov-Marjon E; Serda R; Pastuszyn A; Graham SE; Marcus CB; Omdahl JL
Arch Biochem Biophys; 2007 Apr; 460(2):262-73. PubMed ID: 17207766
[TBL] [Abstract][Full Text] [Related]
12. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24.
St-Arnaud R
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):254-6. PubMed ID: 20144713
[TBL] [Abstract][Full Text] [Related]
13. Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3-26,23-lactone.
Prosser DE; Kaufmann M; O'Leary B; Byford V; Jones G
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12673-8. PubMed ID: 17646648
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analysis of vitamin D 24-hydroxylase (CYP24A1) by site-directed mutagenesis: amino acid residues responsible for species-based difference of CYP24A1 between humans and rats.
Hamamoto H; Kusudo T; Urushino N; Masuno H; Yamamoto K; Yamada S; Kamakura M; Ohta M; Inouye K; Sakaki T
Mol Pharmacol; 2006 Jul; 70(1):120-8. PubMed ID: 16617161
[TBL] [Abstract][Full Text] [Related]
15. 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.
Luo W; Hershberger PA; Trump DL; Johnson CS
J Steroid Biochem Mol Biol; 2013 Jul; 136():252-7. PubMed ID: 23059474
[TBL] [Abstract][Full Text] [Related]
16. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
[TBL] [Abstract][Full Text] [Related]
17. Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites.
Dai B; David V; Alshayeb HM; Showkat A; Gyamlani G; Horst RL; Wall BM; Quarles LD
Kidney Int; 2012 Nov; 82(10):1061-70. PubMed ID: 22739976
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450-mediated metabolism of vitamin D.
Jones G; Prosser DE; Kaufmann M
J Lipid Res; 2014 Jan; 55(1):13-31. PubMed ID: 23564710
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1.
Tieu EW; Li W; Chen J; Kim TK; Ma D; Slominski AT; Tuckey RC
J Steroid Biochem Mol Biol; 2015 May; 149():153-65. PubMed ID: 25727742
[TBL] [Abstract][Full Text] [Related]
20. Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.
Fencl F; Bláhová K; Schlingmann KP; Konrad M; Seeman T
Eur J Pediatr; 2013 Jan; 172(1):45-9. PubMed ID: 23001465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
